Profound Medical Corp's stock sees a modest increase amidst upcoming financial announcements.
This week, Profound Medical Corp (PRN.TO) has experienced a slight uptick in its stock price, closing at C$9.86, which is a daily increase of 2.29%. However, the stock has declined by 1.60% over the past week. Investors are closely watching the company as it prepares to release its Q2 2026 financial results and showcase its innovative TULSA-PRO® technology at several upcoming conferences.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeAdvertisement
Market cap
$353.93M
52W high
$12.40
52W low
$5.23
1W change
-13.29%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 157.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+157.5% Upside
Current Price
C$9.72
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
59.9%
Annualized
90-Day Vol
54.1%
Annualized
Trend (90d)
+9.2%
Annualized drift
90d Mean
C$10.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.83 | C$7.99 – C$12.08 |
| 60 trading days | C$9.93 | C$7.42 – C$13.31 |
| 90 trading days | C$10.04 | C$7.02 – C$14.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a current market cap of approximately C$348.84 million and a significant implied upside according to analyst targets, investors may want to keep an eye on Profound Medical's upcoming announcements and performance metrics to gauge future growth potential.
Profound Medical Corp's stock closed at C$9.86, reflecting a 2.29% increase today.
The stock has a 52-week range of C$5.23 to C$12.40, suggesting it has recently traded at 65% of its range, indicating some room for growth or volatility.
Bull case
The company has reported strong Q1 2026 financial results, showing operational growth. Additionally, the upcoming presentations of TULSA-PRO® technology at key industry conferences could boost visibility and drive future sales.
Bear case
Despite the recent uptick, Profound Medical has a negative profit margin and a high beta of 0.53, indicating potential volatility. The stock is also down 6.92% year-to-date, which may raise concerns among risk-averse investors.
Recent Price Action
Advertisement
Profound Medical Corp's stock closed at C$9.86, marking a 1D increase of 2.29%. Over the past week, however, the stock has decreased by 1.60%. Year-to-date, the stock has declined by 6.92%, reflecting a challenging market environment for the company.
Upcoming Announcements
The company recently announced plans to release its Q2 2026 financial results on August 6, 2026, followed by a conference call. Additionally, Profound Medical's TULSA-PRO® technology is set to feature prominently at several major medical conferences, including the Society of Robotic Surgery and the American Urological Association.
Technical Picture
The stock is currently trading above both its 50-day moving average (C$9.60) and its 200-day moving average (C$9.28), indicating a potential bullish trend. The 52-week range for PRN.TO is C$5.23 to C$12.40, with the current price at 65% of this range. The stock has a beta of 0.53, suggesting lower volatility compared to the broader market. Recent trading volume was 3,200 shares, significantly below the 20-day average of 13,126 shares, indicating reduced investor activity.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
